Premium
Psychiatric symptoms in male cannabis users not using other illicit drugs
Author(s) -
Troisi Alfonso,
Pasini Augusto,
Saracco Michele,
Spalletta Gianfranco
Publication year - 1998
Publication title -
addiction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.424
H-Index - 193
eISSN - 1360-0443
pISSN - 0965-2140
DOI - 10.1046/j.1360-0443.1998.9344874.x
Subject(s) - cannabis , psychiatry , cannabis dependence , anxiety , depression (economics) , psychology , substance abuse , abstinence , medicine , beck depression inventory , clinical psychology , cannabidiol , economics , macroeconomics
Aim. To assess the prevalence of DSM‐III‐R axes I and II disorders and the severity of psychiatric symptoms in cannabis users who did not use other illicit drugs . Design. Cross‐sectional psychiatric examination of subjects with different patterns of cannabis use: cannabis dependence, abuse and occasional use . Participants. One hundred and thirty‐three cannabis users identified through random urine testing of draftees to the Italian army and interviewed after 2‐5 days of abstinence from drug use . Measurements. The subjects completed the Beck Depression Inventory, the Spielberger State‐Trait Anxiety Index and the 20‐item revised Toronto Alexithymia Scale and were then interviewed with the Structured Clinical Interview for DSM‐III‐R . Findings. The prevalence of co‐morbid psychiatric disorders varied with the pattern of cannabis use: 83% of subjects with DSM‐III‐R cannabis dependence, 46% of those with DSM‐III‐R cannabis abuse and 29% of occasional users received at least one DSM‐III‐R psychiatric diagnosis. The severity of depressive, anxious and alexithymic symptoms increased progressively with the degree of involvement with cannabis . Conclusions. In this sample of young men, the risk of associated psychiatric disabilities varied with the pattern of cannabis use. Chronic use of cannabis was associated with a high prevalence of co‐morbid psychiatric disorders.